NASA celebrates a decade observing climate impacts on health of worl...(Web's growth from its beginning. Wh...)
Navigation Links
NASA celebrates a decade observing climate impacts on health of world's oceans
Date:9/22/2007
Web's growth from its beginning.
When the SeaWiFS program launched in 1997, the goal was to place a sensor in space capable of routinely monitoring ocean color to better understand the interplay between the ocean and atmosphere and most importantly, the ocean's role in the global carbon cycle. A decade later, Feldman said, "SeaWiFS has exceeded everyone's expectations."
'/>"/>
| Contact: Lynn Chandler lynn.chandler-1@nasa.gov 301-286-2806 NASA/Goddard Space Flight Center Source:Eurekalert |
Related biology news :
1. Research shows smoking adds a decade to reproductive age of IVF patients
2. New tiger report release: Tiger habitat down from just a decade ago
3. Survivors of childhood polio do well decades later as they age
4. Chronic pain up almost 40 percent among US workers in past decade
5. New findings blow a decade of assumptions out of the water
6. Scientists find fossil proof of Egypts ancient climate
7. Small species back-up giant marsupial climate change extinction claim
8. Africa to take it on chin again with climate change
9. Ocean climate predicts elk population in Canadian Rockies
10. Deep sea algae connect ancient climate, carbon dioxide and vegetation
11. Climate model links higher temperatures to prehistoric extinction
Post Your Comments:
Breaking Biology News(10 mins):Synthetic protein mimics structure, function of metalloprotein in nature 2Study reveals H1N1 unexpected weakness 2Successful stem cell therapy for treatment of eye disease 2Burrill 26amp 3B Company and WR Hambrecht + Co to Collaborate on OpenIPO 28R 29 Transactions 14409 1Burrill 26amp 3B Company and WR Hambrecht + Co to Collaborate on OpenIPO 28R 29 Transactions 14409 2Burrill 26amp 3B Company and WR Hambrecht + Co to Collaborate on OpenIPO 28R 29 Transactions 14409 3Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 1Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 2Stereotaxis Announces Pricing of 2426 Million Common Stock Offering 5364 3Researchers report benefits of new standard treatment study for rare pediatric brain cancer 59211 1Researchers report benefits of new standard treatment study for rare pediatric brain cancer 59211 2
Other Biology News:Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily 2Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily 3FDA sees nanotech challenges in every product category it regulates 2Art and music for the birds 2
Breaking Biology Technology:La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3
[0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum[0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease[0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes
Other Biology Technology:MIT reports finer lines for microchips 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 3Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |